Jcr Pharmaceuticals Co., Ltd.

Jun-ichi Kajihara

Kozue Shibata

Kazuo Kato

Kazuo Katoh

Sei Kirihara

Kazuyuki Hirano

Aki Asada

Hiroko Abe

Guoji Ye

According to the present invention, there are provided inhibitors against prostate-specific antigen which comprise as a minimum unit a peptide consisting of Gly-Phe-Tyr-Lys-Lys-Lys-Gln-Ser-Arg, and such inhibitors can be expected to constitute a therapeutic drug against prostate carcinoma and prostate hyperplasia.

Inhibitors against prostate-specific antigen

The present invention permits human urinary thrombomodulin to be purified by a simple and practical procedure, while it enables even a starting material with a lowered content of thrombomodulin to be purified by greater purification rate than the one with a high content of thrombomodulin.

Method for purifying thrombomodulin

A remitting agent for nephrotic syndrome and hepatopathy symptoms is provided that which comprises water-soluble polysaccharides having poly-D-galacturonic acid as an effective constituent; polysaccharides having the following characteristic properties which are extractable from Tanjin with water or an aqueous solvent: A. Sugar content: 60 to 100%.

Remitting agent for nephrotic syndrome and hepatopathy symptoms

Growing community of inventors

Kobe, Japan

Jun-ichi Kajihara